Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06611748

Restoration of Hand Function in Cervical SCI

Sponsor: MetroHealth Medical Center

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate a new method of restoring hand function to people with spinal cord injury. Current methods to restore hand function include tendon transfers and nerve transfers. This study will evaluate the grasp strength that can be achieved with a small, implantable stimulator. KeyGrip is an investigational device that works by activating paralyzed muscles with low levels of electrical current. The word "investigational" means the study device is still being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA) for the use being studied. Hypothesis. The study is designed to explore the feasibility of this approach; no hypothesis is planned at this stage

Official title: Evaluation of a Simple Neuroprosthesis for Restoration of Hand Function in Cervical Spinal Cord Injury

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

Start Date

2025-01-01

Completion Date

2030-11

Last Updated

2026-02-24

Healthy Volunteers

Conditions

Spinal Cord Injury Cervical

Interventions

DEVICE

Key Grip

KeyGrip is an implantable peripheral nerve stimulator that is being studied for its ability to provide coordinated activation of innervated paralyzed muscles. KeyGrip will be configured to activate nerves of the upper extremity (arm and hand) in order to facilitate movements such as hand opening and/or closing

DEVICE

Implanted Key Grip Electrodes

The KeyGrip System uses modified implanted wires (called "electrodes") that deliver stimulation to the muscles. These electrodes are also investigational.

Inclusion Criteria: * Male or female adults 18 years of age or older; * Cervical spinal cord injury as defined by: a) International Standard for Neurological Classification of Spinal Cord Injury motor level of C1 through C7; and b) American Spinal Injury Association Impairment Scale (AIS) grade A, B, or C; * Six months or more post-injury (neurostability); * Neurologically stable following any nerve transfers affecting the upper extremity (typically, one-year post-surgery); * Musculoskeletally and neurologically stable following any tendon transfers affecting the upper extremity (typically 6 months post-surgery). * Peripheral nerve innervation to upper extremity muscles, including Grade 3/5 or higher Stimulated Manual Muscle Testin at least two of the muscles in one arm: * Good proximal voluntary upper extremity strength as defined by biceps/ brachialis / brachioradialis strength of 2/5 or higher on Manual Muscle Testing the side intended for implantation; * Medically stable; and * Able to understand and provide informed consent; Exclusion Criteria: * Other neurological conditions (Multiple Sclerosis, diabetes with peripheral nerve involvement); * Associated peripheral nerve / brachial plexus injury; * Progressive Spinal Cord Injury; * Active implantable medical device (AIMD) such as a pacemaker or defibrillator; * Active untreated infection such as urinary tract infection or pneumonia; * Active pressure injury; * History of coagulopathy, HIV, cardiopulmonary disease, bradycardia, poorly controlled autonomic dysreflexia, or chronic obstructive pulmonary disease that would preclude safe participation in the trial as determined by the investigator; * Unhealed fractures that prevent functional use of arm; * Extensive upper extremity denervation (fewer than two excitable hand muscles); * Involvement in other ongoing clinical studies that exclude concurrent involvement in this study; * Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant based on self-report); Urine or serum testing will happen during the pre-surgery evaluation. * Presence of disease that might interfere with participant safety, compliance, or evaluation of the condition under study; * Other significant medical findings that, in the opinion of the investigator, preclude safe participation in the trial

Locations (1)

MetroHealth Medical Center

Cleveland, Ohio, United States